These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19074102)

  • 1. Skeletal imaging and management of bone disease.
    Roodman GD
    Hematology Am Soc Hematol Educ Program; 2008; ():313-9. PubMed ID: 19074102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of bone lesions in multiple myeloma].
    Hata H; Mitsuya H
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1072-6. PubMed ID: 16912524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of bone disease in multiple myeloma].
    Izumi T
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1187-90. PubMed ID: 22902442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
    Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
    Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
    In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
    Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
    J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.
    Pianko MJ; Terpos E; Roodman GD; Divgi CR; Zweegman S; Hillengass J; Lentzsch S
    Clin Cancer Res; 2014 Dec; 20(23):5888-97. PubMed ID: 25294899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloma bone disease and treatment options.
    Yeh HS; Berenson JR
    Eur J Cancer; 2006 Jul; 42(11):1554-63. PubMed ID: 16797971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in imaging and the management of myeloma bone disease.
    Terpos E; Moulopoulos LA; Dimopoulos MA
    J Clin Oncol; 2011 May; 29(14):1907-15. PubMed ID: 21483016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of multiple myeloma-related bone disease].
    Jurczyszyn A; Grosicki S; Czerniuk MR; Morga R; Małecki K; Skotnicki AB
    Przegl Lek; 2013; 70(11):950-7. PubMed ID: 24697037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Imaging techniques in multiple myeloma].
    Ozaki S
    Nihon Rinsho; 2007 Dec; 65(12):2261-7. PubMed ID: 18069271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloma bone disease.
    Callander NS; Roodman GD
    Semin Hematol; 2001 Jul; 38(3):276-85. PubMed ID: 11486316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of FDG PET in the assessment of patients with multiple myeloma.
    Bredella MA; Steinbach L; Caputo G; Segall G; Hawkins R
    AJR Am J Roentgenol; 2005 Apr; 184(4):1199-204. PubMed ID: 15788594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current approaches in multiple myeloma and other cancer-related bone diseases].
    Engelhardt M; Kleber M; Udi J; Wäsch R
    Dtsch Med Wochenschr; 2012 May; 137(20):1057-61. PubMed ID: 22549292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and management of myeloma bone disease.
    Christoulas D; Terpos E; Dimopoulos MA
    Expert Rev Hematol; 2009 Aug; 2(4):385-98. PubMed ID: 21082944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws.
    Chiandussi S; Biasotto M; Dore F; Cavalli F; Cova MA; Di Lenarda R
    Dentomaxillofac Radiol; 2006 Jul; 35(4):236-43. PubMed ID: 16798918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw.
    Dore F; Filippi L; Biasotto M; Chiandussi S; Cavalli F; Di Lenarda R
    J Nucl Med; 2009 Jan; 50(1):30-5. PubMed ID: 19091894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging treatment approaches for myeloma-related bone disease.
    Gavriatopoulou M; Dimopoulos MA; Kastritis E; Terpos E
    Expert Rev Hematol; 2017 Mar; 10(3):217-228. PubMed ID: 28092987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone lesion in multiple myeloma].
    Ise M; Takagi T
    Nihon Rinsho; 2007 Dec; 65(12):2224-8. PubMed ID: 18069264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone disease in multiple myeloma.
    Drake MT
    Oncology (Williston Park); 2009 Dec; 23(14 Suppl 5):28-32. PubMed ID: 20128326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.